NCAM1 and acute lymphoblastic leukemia: In a subgroup of 15 patients (13 DLBCL and 2 B-ALL) treated at the Hematology Center in Rome, the circulating NK cells (CD3−/CD56+/CD16+), characterized using flow cytometry, were evaluated as absolute number × 109/L.